市场调查报告书
商品编码
1097148
製药机器人市场规模、份额、趋势分析报告:2022~2030产品(传统机器人、协作机器人)、应用(拣选和包装、实验室应用)、最终应用、地区细分市场预测Pharmaceutical Robots Market Size, Share & Trends Analysis Report By Product (Traditional Robots, Collaborative Robots), By Application (Picking & Packaging, Laboratory Applications), By End-use, By Region, And Segment Forecasts, 2022 - 2030 |
根据 Grand View Research, Inc. 的最新报告,预计到 2030 年,全球製药机器人市场规模将达到 3.579 亿美元。
从 2022 年到 2030 年,市场预计将以 9.2% 的复合年增长率增长。随着製药业的发展和产量和产品质量的提高,生产灵活性的提高,空间利用率的降低,工人流动率的降低,运营成本的降低,以及机器人系统在产品製造中提供的健康. 许多好处,包括提高安全性、减少生产停机时间和改进废物管理,正在推动这些产品的采用并推动市场增长。
根据 Mint 于 2020 年 4 月发表的一篇文章,印度 13 亿多人口的医护人员数量很少,因此儘管价格很高,但它可以用于所有类型的医疗保健环境。预计机器人技术的使用将会增加。 COVID-19 大流行正在为市场打开机会。希望利用其在北美和欧洲的前景的製药公司越来越多地转向机器人。根据机器人工业协会(IRA)的数据,与 2019 年相比,2020 年北美生命科学公司的机器人订单增加了 69%。
随着 COVID-19 的爆发,製药行业正在增加使用机器人来优化程序。机器人将部署在北美和欧洲,以降低流程成本和復杂性。最近,作为解决因生产延迟而导致的药品短缺的解决方案,引起了人们的关注。製药公司预计将与机器人解决方案提供商合作,将机器人技术纳入其製造、药物开发和防伪程序。随着公司增加对製药领域的投资,未来几年机器人的使用可能会增加。
2021 年,由于传统机器人产品在物料搬运、拣选、包装、码垛和检验方面的应用越来越广泛,其收入份额将最大。预计协作机器人将在预测区间内记录最快的增长率。许多公司正在用协作机器人和协作机器人(人机组合)取代传统机器人。协作机器人之所以被广泛采用,是因为它们将机器人的重复性任务与人类的个人技能相结合,以简化製造过程。此外,这些机器比传统机器更便宜,更易于操作和维护。
2021 年,拣选和包装应用领域将占据最大的收入份额,预计在预测期内将呈现最快的增长。这种增长可能主要是由于对个性化包装的高需求以及与该细分市场相关的好处,例如快速、高效的追踪和空间的最佳利用。此外,所有传统的机器人解决方案主要用于拣选和包装。例如,Denso Wave Incorporated 开发的 VP-6242G 和 VS-068A2 等 6 轴多关节机器人可实现拣选和包装。
预计 2021 年,製药公司的最终用途板块在预测期内的收入份额最大,增长率最快。这是由于机器人技术在药物发现和开发中的使用越来越多。製药公司也参与了个性化医疗的开发,这进一步推动了该领域的增长。实验室将在预测间隔期间显着增长,以利用这些自动化解决方案执行重复性任务(例如药物发现活动中的体外和液体运动)的能力来提高一致性和准确性。
2021 年,预计亚太地区将主导市场,并在预测期内创下最快的增长率。对药品生产的需求不断增加,以及为製药公司开髮用于执行高速、降低污染风险、准确性和优化空间利用等任务的机器人机器,正在推动该地区的市场增长。此外,越来越多的政府举措增加了工业机器人的采用率,进一步推动了区域市场的增长。例如,2016年,中国政府启动了《机器人产业发展规划(2016-2020年)》,旨在推动机器人在更广泛领域的应用和吸引外资,到2020年将采用国产技术进行生产。目标是每年发展10万台工业机器人。
The global pharmaceutical robots market size is expected to reach USD 357.9 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2022 to 2030. The growing pharmaceutical industry and numerous benefits offered by robotic systems in product manufacturing, such as improved production output and product quality, increased production flexibility, lesser space utilization, no labor turnover, low operating costs, enhanced health and safety, reduced production downtime, and better waste management, are driving the adoption of these products, thereby aiding the market growth.
According to an article published by Mint in April 2020, the adoption and usage of robotic technology are expected to increase in India across all types of healthcare settings, despite their high prices, owing to the availability of a smaller number of healthcare professionals for more than 1.3 billion population. The market is seeing opportunities due to the COVID-19 pandemic. Pharmaceutical companies looking to capitalize on prospects in North America and Europe are increasingly turning to robots. According to the Robotic Industries Association (IRA), orders for robots from North American life science companies increased by 69% in 2020 compared to 2019.
The COVID-19 outbreak has prompted the pharmaceutical industry to increase its use of robots to optimize procedures. Robots will continue to be deployed in North America and Europe to cut the process's costs and complexity. It has recently gained interest as a solution to medicine shortages caused by production delays. Pharmaceutical companies are anticipated to form partnerships with robotics solution providers to incorporate robotics into manufacturing, medication development, and anti-counterfeiting procedures. As companies increase their investments in the pharmaceutical sector, the use of robots may grow in the coming years.
In 2021, the traditional robots product segment accounted for the largest revenue share owing to its increasing adoption in material handling, picking and packaging, palletizing, and inspection. Collaborative robots are anticipated to register the fastest growth rate during the forecast period. Many companies are replacing traditional with collaborative robots or cobots, which is a combination of humans and robotics. The adoption of cobots is significantly increasing as they combine repetitive tasks of robots and the individual skills of humans to bring in efficiency in manufacturing processes. These machines are also cheaper and easier to operate and maintain as compared to the traditional ones.
In 2021, the picking and packaging application segment accounted for the largest revenue share and is anticipated to witness the fastest growth during the forecast period. This growth can mainly be attributed to the high demand for personalized packaging and benefits associated with this segment, including high speed, efficient track and trace, and optimum utilization of the floor space. In addition, all the traditional robotic solutions are mainly used for picking and packaging. For instance, 6-axis articulated robots such as VP-6242G and VS-068A2 developed by Denso Wave Incorporated enable picking and packaging.
In 2021, the pharmaceutical companies end-use segment accounted for the largest revenue share and is anticipated to register the fastest growth rate during the forecast period. This is attributed to the increasing usage of robotics in drug discovery and development. In addition, pharmaceutical companies are involved in developing personalized medicine, which further supports the growth of the segment. Research laboratories are anticipated to witness significant growth during the forecast period owing to the ability of these automated solutions to perform repetitive tasks, such as moving test tubes and fluids, during drug discovery-related activities, facilitating a high rate of consistency and accuracy.
In 2021, Asia Pacific dominated the market and is anticipated to register the fastest growth rate during the forecast period. The rise in the demand for the production of drugs and the development of robotic machines for performing tasks with high speed, reduced risk of contamination, accuracy, and optimum utilization of space among pharmaceutical companies is boosting the regional market growth. Moreover, a rise in the number of initiatives undertaken by the government to increase the adoption of industrial robots is further aiding the regional market growth. For instance, in 2016, the Chinese government launched the Robotics Industry Development Plan (2016-2020), aimed at promoting robot applications to a wider range of fields and attracting foreign investment, to develop 100,000 industrial robots produced by domestic technology annually by 2020.